Concurrent Radiation and Immunotherapy-Reference-Cited by-同舟云学术

Concurrent Radiation and Immunotherapy

Published:2019-02 Issue:2 Volume:42 Page:208-214
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Amin Neha P.,Remick Jill,Agarwal Manuj,Desai Nina A.,Bergom Carmen,Simone Charles B.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference51 articles.

1. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody;Dewan;Clin Cancer Res,2009

2. The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant;Reynders;Cancer Treat Rev,2015

3. Stereotactic radiation therapy combined with immunotherapy: augmenting the role of radiation in local and systemic treatment;Sharabi;Oncology (Williston Park),2015

4. Optimizing timing of immunotherapy improves control of tumors by hypofractionated radiation therapy;Young;PLoS ONE,2016

5. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice;Deng;J Clin Invest,2014

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An International Consensus on the Design of Prospective Clinical–Translational Trials in Spatially Fractionated Radiation Therapy for Advanced Gynecologic Cancer;Cancers;2022-08-31

2. In Regard to Damen et al.;International Journal of Radiation Oncology*Biology*Physics;2022-05

3. An International Consensus on the Design of Prospective Clinical–Translational Trials in Spatially Fractionated Radiation Therapy;Advances in Radiation Oncology;2022-03

4. Hypofractionated radiotherapy combined with targeted therapy or immunotherapy: Dutch survey on current practice, knowledge and challenges;Clinical and Translational Radiation Oncology;2022-03

5. Combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer;Translational Lung Cancer Research;2021-12